Net result : no systemic 5AR inhibition even with a 5mg injection
Semaglutide 2.65 mg/ml + L-carnitine 100 mg/ml is a Glucagon-like peptide receptor agonist and is an injectable prescription medicine used for adults with obesity (BMI 30) or overweight (excess weight) (BMI 27) who also have weight-related medical problems to help them lose weight and keep the weight off
The injectable formulation is what produced the 15% weight loss benchmark in the STEP 1 trial meaningful added efficacy on top of the cost cut
It touches systems that also respond to estrogen, progesterone, cortisol, and thyroid hormones
Generally, elderly patients diagnosed with type 2 diabetes or obesity can safely take semaglutide to improve glycemic control and curb the risk of cardiovascular events
So yeah, theyre definitely handing it out, whether its all needed or whatever is a different story